The Aruna Shanbaug judgment (2011) initially mandated that any decision to withdraw life support for a patient in PVS required the approval of the concerned High Court, which was to act as the patient's guardian. This was a stringent safeguard. The Common Cause judgment (2018) later introduced the involvement of a Judicial Magistrate First Class (JMFC) to verify the 'Living Will' and the medical board's decision. However, the 2023 Supreme Court modifications simplified this process significantly. The direct role of the High Court was removed, and the JMFC's role was also reduced. Now, the primary decision-making lies with two medical boards (primary and secondary) formed by the hospital, with the JMFC's role limited to endorsing the medical board's decision without requiring a detailed inquiry, thereby streamlining the process.

The practical application of passive euthanasia has been slow due to several challenges. These include the difficulty in finding sufficient expert doctors with the necessary experience across all hospitals, the reluctance of medical professionals to take such a grave decision, and the slow progress by states in creating lists of nominated doctors for secondary medical boards. The recent Harish Rana case (2026), where the Supreme Court allowed the withdrawal of life-sustaining treatment for a 32-year-old man in PVS for over 13 years, is highly significant. It is considered the first practical application of India's simplified passive euthanasia framework, demonstrating that the process, though challenging, is now being successfully invoked and implemented, marking a crucial step towards its operationalization.

This is a profound ethical and legal dilemma. To balance the 'sanctity of life' with the 'right to die with dignity', it's crucial to understand the Supreme Court's narrow interpretation. Passive euthanasia is not a general right to end one's life at will, nor does it apply to curable conditions. It is strictly limited to cases of irreversible Persistent Vegetative State (PVS) where there is no hope of recovery, and the individual is suffering without consciousness. The elaborate safeguards, including multiple medical board approvals and judicial oversight (even if simplified), are designed precisely to uphold the sanctity of life by ensuring that such decisions are not taken lightly or arbitrarily. The 'right to die with dignity' in this context means preventing prolonged suffering and allowing a natural, dignified end when life has irreversibly lost its quality and meaning, rather than actively terminating it. It's about respecting autonomy in extreme, hopeless medical situations, not devaluing life itself.

The Aruna Shanbaug judgment drew a clear and crucial distinction: 'Active euthanasia' involves intentionally taking a direct action to end a person's life, such as administering a lethal injection. This is considered illegal under Indian law, amounting to murder or abetment to suicide. 'Passive euthanasia', on the other hand, involves withholding or withdrawing life-sustaining treatment, allowing the patient to die naturally from their underlying condition. The judgment legalized passive euthanasia under very strict conditions, primarily for patients in an irreversible Persistent Vegetative State (PVS) with no hope of recovery. This distinction is crucial for UPSC exams because questions often test your understanding of which form of euthanasia is permissible, under what conditions, and the legal implications of each, particularly in the context of Article 21 and medical ethics.

The Aruna Shanbaug judgment (2011) initially mandated that any decision to withdraw life support for a patient in PVS required the approval of the concerned High Court, which was to act as the patient's guardian. This was a stringent safeguard. The Common Cause judgment (2018) later introduced the involvement of a Judicial Magistrate First Class (JMFC) to verify the 'Living Will' and the medical board's decision. However, the 2023 Supreme Court modifications simplified this process significantly. The direct role of the High Court was removed, and the JMFC's role was also reduced. Now, the primary decision-making lies with two medical boards (primary and secondary) formed by the hospital, with the JMFC's role limited to endorsing the medical board's decision without requiring a detailed inquiry, thereby streamlining the process.

The practical application of passive euthanasia has been slow due to several challenges. These include the difficulty in finding sufficient expert doctors with the necessary experience across all hospitals, the reluctance of medical professionals to take such a grave decision, and the slow progress by states in creating lists of nominated doctors for secondary medical boards. The recent Harish Rana case (2026), where the Supreme Court allowed the withdrawal of life-sustaining treatment for a 32-year-old man in PVS for over 13 years, is highly significant. It is considered the first practical application of India's simplified passive euthanasia framework, demonstrating that the process, though challenging, is now being successfully invoked and implemented, marking a crucial step towards its operationalization.

This is a profound ethical and legal dilemma. To balance the 'sanctity of life' with the 'right to die with dignity', it's crucial to understand the Supreme Court's narrow interpretation. Passive euthanasia is not a general right to end one's life at will, nor does it apply to curable conditions. It is strictly limited to cases of irreversible Persistent Vegetative State (PVS) where there is no hope of recovery, and the individual is suffering without consciousness. The elaborate safeguards, including multiple medical board approvals and judicial oversight (even if simplified), are designed precisely to uphold the sanctity of life by ensuring that such decisions are not taken lightly or arbitrarily. The 'right to die with dignity' in this context means preventing prolonged suffering and allowing a natural, dignified end when life has irreversibly lost its quality and meaning, rather than actively terminating it. It's about respecting autonomy in extreme, hopeless medical situations, not devaluing life itself.

The Aruna Shanbaug judgment drew a clear and crucial distinction: 'Active euthanasia' involves intentionally taking a direct action to end a person's life, such as administering a lethal injection. This is considered illegal under Indian law, amounting to murder or abetment to suicide. 'Passive euthanasia', on the other hand, involves withholding or withdrawing life-sustaining treatment, allowing the patient to die naturally from their underlying condition. The judgment legalized passive euthanasia under very strict conditions, primarily for patients in an irreversible Persistent Vegetative State (PVS) with no hope of recovery. This distinction is crucial for UPSC exams because questions often test your understanding of which form of euthanasia is permissible, under what conditions, and the legal implications of each, particularly in the context of Article 21 and medical ethics.